by Renee Wadsworth | Jul 25, 2024 | Hematology-Oncology
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement...
by Renee Wadsworth | Jul 25, 2024 | Neurology
The goal of this initiative is to improve the care of patients with Duchenne muscular dystrophy (DMD). DMD is the most common childhood form of muscular dystrophy and characteristic manifestations are progressive muscle weakness, cardiorespiratory impairment, and...
by Renee Wadsworth | Jul 25, 2024 | Rheumatology
Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, can prove challenging to address in real-world settings. Although biologics directed against TNF-α can rapidly and sustainably induce clinical...
by Renee Wadsworth | Jul 25, 2024 | Dermatology
Managed care professionals are not on the forefront of dermatologic care for those pediatric and adult patients living with atopic dermatitis. In this program, learners will explore the challenges patients living with atopic dermatitis face and they will identify...
by Renee Wadsworth | Jul 25, 2024 | Hematology-Oncology
This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell...
